These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 30548085)
1. Different outcomes in sporadic versus familial medullary thyroid cancer. Saltiki K; Simeakis G; Anagnostou E; Zapanti E; Anastasiou E; Alevizaki M Head Neck; 2019 Jan; 41(1):154-161. PubMed ID: 30548085 [TBL] [Abstract][Full Text] [Related]
2. Clinico-pathologic and dynamic prognostic factors in sporadic and familial medullary thyroid carcinoma: an Israeli multi-center study. Twito O; Grozinsky-Glasberg S; Levy S; Bachar G; Gross DJ; Benbassat C; Rozental A; Hirsch D Eur J Endocrinol; 2019 Jul; 181(1):13-21. PubMed ID: 31048559 [TBL] [Abstract][Full Text] [Related]
3. Long-Term Outcomes and Aggressiveness of Hereditary Medullary Thyroid Carcinoma: 40 Years of Experience at One Center. Raue F; Bruckner T; Frank-Raue K J Clin Endocrinol Metab; 2019 Oct; 104(10):4264-4272. PubMed ID: 31145454 [TBL] [Abstract][Full Text] [Related]
4. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma. Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880 [TBL] [Abstract][Full Text] [Related]
5. Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems. Kebebew E; Ituarte PH; Siperstein AE; Duh QY; Clark OH Cancer; 2000 Mar; 88(5):1139-48. PubMed ID: 10699905 [TBL] [Abstract][Full Text] [Related]
6. Sporadic and Familial Medullary Thyroid Carcinoma: A Retrospective Single Center Study on Presentation and Outcome. Prinzi A; Vella V; Bosco A; Mirone A; Russo M; Piticchio T; Di Benedetto G; Bartoloni G; Frasca F; Malandrino P Endocr Res; 2024; 49(4):179-185. PubMed ID: 39419111 [TBL] [Abstract][Full Text] [Related]
7. Predicting Outcomes in Sporadic and Hereditary Medullary Thyroid Carcinoma over Two Decades. Kotwal A; Erickson D; Geske JR; Hay ID; Castro MR Thyroid; 2021 Apr; 31(4):616-626. PubMed ID: 33108969 [No Abstract] [Full Text] [Related]
8. Similar Stage-dependent Survival and Outcome in Sporadic and Hereditary Medullary Thyroid Carcinoma. Raue F; Bruckner T; Frank-Raue K J Clin Endocrinol Metab; 2021 Aug; 106(9):e3582-e3591. PubMed ID: 33974051 [TBL] [Abstract][Full Text] [Related]
9. Clinical utility of genetic diagnosis for sporadic and hereditary medullary thyroid carcinoma. Elisei R; Bottici V; Cappagli V; Ramone T; Tacito A; Ciampi R; Romei C Ann Endocrinol (Paris); 2019 Jun; 80(3):187-190. PubMed ID: 31053251 [TBL] [Abstract][Full Text] [Related]
10. Long-Term Outcome After Surgery for Medullary Thyroid Carcinoma: A Single-Center Experience. Torresan F; Cavedon E; Mian C; Iacobone M World J Surg; 2018 Feb; 42(2):367-375. PubMed ID: 29134313 [TBL] [Abstract][Full Text] [Related]
11. C-cell hyperplasia in sporadic and familial medullary thyroid carcinoma. Yadav M; Agrawal V; Pani KC; Verma R; Jaiswal S; Mishra A; Pandey R Indian J Pathol Microbiol; 2018; 61(4):485-488. PubMed ID: 30303134 [TBL] [Abstract][Full Text] [Related]
12. Survival and Long-Term Biochemical Cure in Medullary Thyroid Carcinoma in Denmark 1997-2014: A Nationwide Study. Mathiesen JS; Kroustrup JP; Vestergaard P; Stochholm K; Poulsen PL; Rasmussen ÅK; Feldt-Rasmussen U; Schytte S; Londero SC; Pedersen HB; Hahn CH; Bentzen J; Möller S; Gaustadnes M; Rossing M; Nielsen FC; Brixen K; Frederiksen AL; Godballe C Thyroid; 2019 Mar; 29(3):368-377. PubMed ID: 30618340 [TBL] [Abstract][Full Text] [Related]
13. Medullary Thyroid Carcinoma: Survival Analysis and Evaluation of Mutation-Specific Immunohistochemistry in Detection of Sporadic Disease. Jayakody S; Reagh J; Bullock M; Aniss A; Clifton-Bligh R; Learoyd D; Robinson B; Delbridge L; Sidhu S; Gill AJ; Sywak M World J Surg; 2018 May; 42(5):1432-1439. PubMed ID: 29484475 [TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid carcinoma in Northern Ireland, 1967-1997. Dolan SJ; Russell CF Ann R Coll Surg Engl; 2000 May; 82(3):156-61. PubMed ID: 10858675 [TBL] [Abstract][Full Text] [Related]
15. RET genetic screening in patients with medullary thyroid cancer and their relatives: experience with 807 individuals at one center. Elisei R; Romei C; Cosci B; Agate L; Bottici V; Molinaro E; Sculli M; Miccoli P; Basolo F; Grasso L; Pacini F; Pinchera A J Clin Endocrinol Metab; 2007 Dec; 92(12):4725-9. PubMed ID: 17895320 [TBL] [Abstract][Full Text] [Related]
16. All in the family? Analyzing the impact of family history in addition to genotype on medullary thyroid carcinoma aggressiveness in MEN2A patients. Long KL; Etzel C; Rich T; Hyde S; Perrier ND; Graham PH; Lee JE; Hu MI; Cote GJ; Gagel R; Grubbs EG Fam Cancer; 2017 Apr; 16(2):283-289. PubMed ID: 27864651 [TBL] [Abstract][Full Text] [Related]
17. Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India. Mehrotra PK; Mishra A; Mishra SK; Agarwal G; Agarwal A; Verma AK World J Surg; 2011 Jun; 35(6):1273-80. PubMed ID: 21479684 [TBL] [Abstract][Full Text] [Related]
18. Presurgical assessment of the tumor burden of familial medullary thyroid carcinoma by calcitonin testing. Pomares FJ; Rodríguez JM; Nicolás F; Sola J; Canteras M; Balsalobre M; Pascual M; Parrilla P; Tébar FJ J Am Coll Surg; 2002 Nov; 195(5):630-4. PubMed ID: 12437249 [TBL] [Abstract][Full Text] [Related]